TMX Newsfile

IN THE PRESS

Pharm Country

Infectious Disease Specialist Will Guide Halberd’s Extracorporeal Elimination of Disease Antigens in Animals and Then Humans

March 16, 2022

·

3 min read

Drug Development

Entheon Biomedical Announces Enrollment in Phase 1 Study of DMT

March 15, 2022

·

5 min read

With a Two-Year Revenue Growth of 252 Percent, PathogenDx Ranks No. 46 on Inc. Magazine’s List of the Southwest Region’s Fastest-Growing Private Companies

March 15, 2022

·

5 min read

Drug Development

NervGen Pharma Receives Approval from Safety Review Committee to Proceed to Second Cohort in Multiple Ascending Dose Portion of Phase 1 Clinical Trial of NVG-291

March 15, 2022

·

7 min read

Business

Awakn Life Sciences Appoints Kevin Lorenz as U.S. Head of Commercial Development

March 15, 2022

·

6 min read

Business

Cardiol Therapeutics Appoints Jennifer M. Chao to Its Board of Directors

March 15, 2022

·

5 min read

Business

MustGrow Appoints Seasoned International Agriculture Professional to Board

March 15, 2022

·

5 min read

Satellos Bioscience Provides Update on Novel Regenerative Drug Candidates

March 15, 2022

·

7 min read

Pacylex Pharmaceuticals Announces Publication in Current Oncology of First Clinical Experience with an N-myristoyltransferase (NMT) inhibitor in a Patient with Diffuse Large B-cell Lymphoma (DLBCL)

March 15, 2022

·

2 min read

Preventing Post-Surgical Abdominal Adhesions: Virtual Presentation on Palisade Bio’s LB1148 Clinical Data; To Be Hosted & Moderated by Stonegate Capital Partners

March 14, 2022

·

1 min read

15 Toronto St., Suite 601 Toronto ON M5C 2E3 US

Tel: 416-806-1750